Which non-drug approaches have been tested for Glaucoma, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.
Evidence-gap matrix
Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.
| Intervention group | Fatigue and energy | Post-exertional symptoms | Cognition | Mood, anxiety and wellbeing | Pain | Sleep | Physical function and exercise capacity | Heart rate, blood pressure and autonomic | Breathing and lung function | Quality of life | Weight and metabolic markers | Inflammation and other biomarkers | Symptom severity and disease activity | Clinical events, survival and healthcare use | Feasibility, adherence and safety | Not classified |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exercise and physical activity | · | · | · | · | · | · | 2 | 3 | · | · | · | · | 1 | · | · | 3 |
| Rehabilitation and therapy services | · | · | · | · | · | · | · | · | · | 1 | · | · | · | · | · | · |
| Breathing and respiratory training | · | · | · | 2 | · | 1 | · | · | · | 2 | · | · | · | · | · | 1 |
| Mind-body and psychological approaches | · | · | 2 | 1 | · | · | · | 1 | · | 2 | · | · | · | · | 3 | 31 with results |
| Cognitive training and education | · | · | · | · | · | · | · | · | · | 2 | · | · | 1 | · | 112 with results | 83 with results |
| Diet, fasting and nutrition | · | · | · | · | · | · | · | · | · | · | · | · | · | 1 | · | 52 with results |
| Sleep and circadian approaches | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 3 |
| Neuromodulation and electrical stimulation | · | · | · | · | · | · | 2 | · | · | · | · | · | · | · | · | 6 |
| Oxygen, light, temperature and manual therapies | · | · | · | · | 1 | · | · | · | · | · | · | · | · | · | · | 10 |
| Supplements and nutraceuticals | · | · | · | · | · | 1 | · | 11 with results | · | · | · | 1 | · | · | · | 20 |
| Other devices and digital tools | · | · | · | · | · | · | 1 | · | · | · | · | · | · | · | · | 31 with results |
| Care delivery and health services | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 31 with results | 11 with results |
| Other behavioural, not yet classified | · | · | · | 2 | 1 | · | 2 | · | · | 1 | · | · | · | · | 61 with results | 61 with results |
The table scrolls sideways: 16 outcome columns.
Where the gaps are
Outcomes not found as a primary outcome in a group's trials
- Among the 23 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (8 trials of other approaches did).
- Among the 11 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (8 trials of other approaches did).
- Among the 9 trials of exercise and physical activity found, none used quality of life as a primary outcome (8 trials of other approaches did).
- Among the 8 trials of neuromodulation and electrical stimulation found, none used quality of life as a primary outcome (8 trials of other approaches did).
- Among the 23 trials of supplements and nutraceuticals found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
- Among the 21 trials of cognitive training and education found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
- Among the 11 trials of mind-body and psychological approaches found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
- Among the 11 trials of oxygen, light, temperature and manual therapies found, none used physical function and exercise capacity as a primary outcome (7 trials of other approaches did).
- Among the 23 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
- Among the 21 trials of cognitive training and education found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
- Among the 11 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
- Among the 9 trials of exercise and physical activity found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
- Among the 8 trials of neuromodulation and electrical stimulation found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
- Among the 21 trials of cognitive training and education found, none used heart rate, blood pressure and autonomic as a primary outcome (4 trials of other approaches did).
Questions studied but with no results posted
- Exercise and physical activity × heart rate, blood pressure and autonomic: 3 trials registered, none with results posted (1 still recruiting)
- Mind-body and psychological approaches × feasibility, adherence and safety: 3 trials registered, none with results posted
Design a trial with DecenTrial (beta) Fund a component of this work
A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.
Most-studied approaches for Glaucoma
Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page
How outcomes are grouped
Each trial's primary outcome measures are sorted into domains by keyword rules. 68 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).
Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.